top of page

AstraZeneca’s new antibiotic Zavicefta approved in the EU

The European Commission (EC) has granted marketing authorisation for AstraZeneca’s combination antibiotic Zavicefta (ceftazidime-avibactam) for the treatment of patients with serious Gram-negative bacterial infections requiring hospitalisation.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page